Results
|
|
1.
|
Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2022
Citation: - Jacc: Cardiovascular Interventions. 15(18):1852-1860, 2022 Sep 26.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R
|
|
|
2.
|
A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE). MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2022
Citation: - Eurointervention. 18(2):e132-e139, 2022 Jun 03.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
All authors: - Garcia-Garcia HM, Haner JD, Luscher TF, Moccetti M, Muller O, Raber L, Roffi M, Siegrist P, Stortecky S, Waksman R
|
|
|
3.
|
Biodegradable polymer sirolimus-eluting stents vs durable polymer everolimus-eluting stents in patients undergoing percutaneous coronary intervention: A meta-analysis of individual patient data from 5 randomized trials. [Review] MedStar authors:
Year: 2021
Citation: - American Heart Journal. 235:140-148, 2021 05.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Asami M, Iglesias JF, Kandzari DE, Koolen J, Lefevre T, Muller O, Piccolo R, Pilgrim T, Rothenbuhler M, Saito S, Siontis GC, Slagboom T, Waksman R, Windecker S
|
|
|
4.
|
Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2020
Citation: - Clinical Therapeutics. 42(4):649-660.e9, 2020 04.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - BIOFLOW VI Trial Investigators, Gao R, Garcia-Garcia HM, Guan C, Han Y, Li C, Song D, Waksman R, Xu B, Xu J, Yang Y
|
|
|
5.
|
Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus. MedStar authors:
- Kolm, Paul
- Lipinski, Michael J
- Shlofmitz, Evan
- Torguson, Rebecca
- Waksman, Ron
Year: 2019
Citation: - American Journal of Cardiology. 124(7):1020-1026, 2019 10 01.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Kandzari D, Kolm P, Koolen JJ, Lipinski MJ, Saito S, Shlofmitz E, Torguson R, Waksman R, Windecker S
|
|
|
6.
|
Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2018
Citation: - Circulation: Cardiovascular Interventions. 11(10):e007331, 2018 Oct.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Marcusohn E, Massaro JM, Roguin A, Waksman R
|
|
|
7.
|
Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2017
Citation: - Lancet. 390(10105):1843-1852, 2017 Oct 21.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R
|
